Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis

Details for Australian Patent Application No. 2009327133 (hide)

Owner MERCK SERONO S.A.

Inventors Muzerelle, Mathilde; Quattropani, Anna; Montagne, Cyril; Dorbais, Jerome

Agent Griffith Hack

Pub. Number AU-A-2009327133

PCT Pub. Number WO2010/069949

Priority 08172177.1 18.12.08 EP; 61/238,261 31.08.09 US

Filing date 15 December 2009

Wipo publication date 24 June 2010

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4525 (2006.01)

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/069949 Priority application(s): WO2010/069949

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009327134-Bidirectional promoter from Z. mais

2009327127-Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD